Evidence map›Paper›PMID 39879194›Full record

ArticlePloS one2025

The impact of anticoagulant-related bleeding on quality of life: Development of a novel measure based on perspectives from older adults.

Anna L Parks, Stacey L Slager, Amy M Cizik, Margaret C Fang, Mark A Supiano, Patti P Katz, Daniel M Witt

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anna L ParksDivision of Hematology & Hematologic Malignancies, University of Utah, Salt Lake City, Utah, United States of America.ORCID 0000-0003-1377-5406
Stacey L SlagerConflict of Interest Office, University of Utah, Salt Lake City, Utah, United States of America.
Amy M CizikDepartment of Orthopedics, University of Utah, Salt Lake City, Utah, United States of America.
Margaret C FangDivision of Hospital Medicine, University of California, San Francisco, California, United States of America.
Mark A SupianoDivision of Geriatrics, University of Utah, Salt Lake City, Utah, United States of America.
Patti P KatzDivision of Rheumatology, University of California, San Francisco, California, United States of America.
Daniel M WittDepartment of Pharmacotherapy, University of Utah, Salt Lake City, Utah, United States of America.

Funding

Use and outcomes of anticoagulants for the treatment and prevention of thrombosis among hospitalized patientsK24HL141354 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FANG, MARGARET C. · 2018 to 2022
$731k
Advancing patient-centered decision making in older adults with venous thromboembolismK76AG083304 · NIA · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Anna L Parks · 2024 to 2026
$729k
Development and Preliminary Validation of a Bleeding Quality of Life PatientReported Outcome Measure for Older AdultsR03AG074074 · NIA · UNIVERSITY OF UTAH · PI PARKS, ANNA L · 2021 to 2022
$305k
AHRQ HHS R18 HS027960NHLBI NIH HHS K24 HL141354NIA NIH HHS K76 AG083304NIA NIH HHS R03 AG074074
6 · The paper itself

Abstract

backgroundVenous thromboembolism (VTE) and atrial fibrillation (AF) disproportionately affect older adults, who are at increased risk of bleeding from treatment with anticoagulant therapy. The impact of bleeding on older adults' quality of life (QoL) is poorly understood due to the lack of a validated measure of their experience. This study's purpose is to describe the first evidence-based steps in developing a new condition-specific patient-reported outcome measure (PROM) for the effect of anticoagulant-related bleeding on older adults' QoL.

methodsAdults aged 65 years and older with VTE or AF at the University of Utah who were eligible for anticoagulation were recruited. We purposely sampled by age, sex, race/ethnicity, diagnosis, bleeding history and anticoagulant. In accordance with evidence-based guidelines for PROM development, focus groups were conducted to refine a hypothesized conceptual model of bleeding-related QoL and analyzed according to hybrid inductive and deductive thematic analysis methods. Focus group results were used to write a draft PROM. Semi-structured qualitative interviews were conducted to revise items on the draft PROM and were analyzed using thematic analysis to generate a final bleeding-related QoL PROM.

resultsTwenty individuals participated in interviews, and nine in two focus groups. Median age was 81 (range 69-95), 52% were women and 69% were White (10% Asian, 10% Hispanic, 7% Black, 3% Native Hawaiian/Pacific Islander). Through inductive and deductive thematic analysis of focus groups, we identified 19 themes (e.g., specific bleeding symptoms, adaptations in relationships, fatigue) that fell into 5 domains: 1) bleeding symptoms, 2) healthcare experiences, 3) social function, 4) emotional function, 5) physical function. These 19 themes and 5 domains formed the basis of the draft PROM. We conducted semi-structured cognitive interviews, and we performed thematic analysis to revise the drafted measure for clarity and relevance. The data resulted in a new PROM for bleeding-related QoL in older adults.

conclusionEmploying evidence-based methods for PROM development, we found that bleeding can have a marked impact on everyday activities, emotional wellbeing and interpersonal relations for older adults. We incorporated these distinct aspects of wellbeing and function into a novel PROM for bleeding-related QoL that can inform clinical care and research after subsequent psychometric validation.

Indexed as

AnticoagulantsAtrial FibrillationHemorrhageQuality of LifeVenous ThromboembolismAgedAged, 80 and overFemaleFocus GroupsHumansMalePatient Reported Outcome MeasuresAnticoagulants

Identifiers

PMID39879194
PMCPMC11778767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.